Movicol® (Sodium Hydrogen Carbonate, Potassium Chloride, Sodium Chloride, Macrogol 3350)

Macrogol 3350 is a high‑molecular‑weight polymer that draws water into the intestinal lumen by creating an osmotic gradient. The retained water softens the stool, while the added electrolytes help maintain fluid balance, resulting in increased bowel motility and easier passage of feces.

The dose of Movicol is individualized by a prescriber based on the patient’s age, condition severity, and response to therapy. Healthcare professionals determine the number of sachets to dissolve in water and the frequency of administration for each specific case.

Safety data for Movicol in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before use.

To order Movicol, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Movicol belongs to the osmotic laxative class, which works by retaining water in the gut, whereas stimulant laxatives such as bisacodyl increase intestinal muscle contractions. Osmotic agents like Movicol are generally gentler and suitable for longer‑term use, while stimulants may cause cramping and are often reserved for occasional relief.

Movicol sachets should be stored at ambient temperature, below 25 °C, in their original packaging to protect from moisture. Keep the product out of direct sunlight and away from heat sources. Do not use if the sachet is damaged or the powder appears discoloured.

Each Movicol sachet is dissolved in a specified volume of water (usually 125 ml) and the solution is consumed immediately after mixing. The drink should be taken with additional fluids as advised by a healthcare professional to maintain adequate hydration.

Serious risks include electrolyte imbalance, severe dehydration, and rare allergic reactions such as rash, swelling or anaphylaxis. Patients should seek medical attention promptly if they experience symptoms like rapid heartbeat, muscle weakness, severe abdominal pain, or signs of an allergic response.

Movicol should be avoided in individuals with known hypersensitivity to macrogol or any of its electrolytes, in patients with intestinal obstruction, perforation, or severe inflammatory bowel disease, and in those with uncontrolled heart failure or severe renal impairment unless closely monitored by a physician.